| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.603 | 11.081 | 12.833 | 15.917 | 18.111 | 13.655 | 13.583 | 17.163 | 16.139 | 11.943 |
| Total Income - EUR | 10.380 | 11.117 | 12.833 | 15.917 | 18.111 | 13.655 | 13.583 | 17.163 | 16.139 | 11.943 |
| Total Expenses - EUR | 12.184 | 20.223 | 15.945 | 13.947 | 7.990 | 8.110 | 14.052 | 18.364 | 18.855 | 21.111 |
| Gross Profit/Loss - EUR | -1.804 | -9.106 | -3.112 | 1.970 | 10.121 | 5.545 | -469 | -1.201 | -2.716 | -9.168 |
| Net Profit/Loss - EUR | -2.096 | -9.277 | -3.240 | 1.813 | 9.940 | 5.298 | -869 | -1.457 | -2.875 | -9.526 |
| Employees | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Plus Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 704 | 9.009 | 7.472 | 6.193 | 4.953 | 3.779 | 2.731 | 1.773 | 803 | 0 |
| Current Assets | 36.740 | 1.297 | 124 | 1.801 | 13.494 | 19.425 | 20.129 | 12.507 | 9.599 | 906 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.085 | 0 | 0 |
| Receivables | 648 | 0 | 0 | 0 | 0 | 917 | 861 | 863 | 861 | 0 |
| Cash | 36.092 | 1.297 | 124 | 1.801 | 13.494 | 18.508 | 19.268 | 9.559 | 8.738 | 906 |
| Shareholders Funds | 35.975 | 9.455 | 6.049 | 7.754 | 17.545 | 22.521 | 21.111 | 13.515 | 9.175 | -402 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.469 | 913 | 1.695 | 240 | 902 | 683 | 1.748 | 765 | 1.227 | 1.309 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Plus Med Srl